Initial sites of hepadnavirus integration into host genome in human hepatocytes and in the woodchuck model of hepatitis B-associated hepatocellular carcinoma

Oncogenesis

Volumn 6, Issue 4, 2017, Pages

  Chauhan, R ^a   Churchill, N D ^a   Mulrooney Cousins, P M ^a   Michalak, T I ^a  

^a MEMORIAL UNIVERSITY OF NEWFOUNDLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; MEMBRANE ANTIGEN; MESSENGER RNA; VIRUS DNA;

AMPLICON; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; DNA INTEGRATION; ENHANCER REGION; HEPADNAVIRIDAE; HEPADNAVIRUS INFECTION; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; HUMAN GENOME; HYBRIDIZATION; IN VITRO STUDY; INOCULATION; INVERSE POLYMERASE CHAIN REACTION; LIVER BIOPSY; LIVER CELL; LIVER CELL CARCINOMA; NONHUMAN; NUCLEIC ACID HYBRIDIZATION; PRIORITY JOURNAL; PROMOTER REGION; RETROPOSON; SEQUENCE ANALYSIS; VIRUS CELL INTERACTION; VIRUS DNA CELL DNA INTERACTION; VIRUS REPLICATION; WOODCHUCK; WOODCHUCK HEPATITIS VIRUS;

EID: 85022225201     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2017.22     Document Type: Article

References (64)

1. World Health Organization. . Hepatitis B fact sheet. Revised July. World Health Organization: Geneva, Switzerland, 2015, Available http://www.who.int/media centre/factsheets/fs204/en/. Accessed: 10 April 2016.
2. Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nat Rev Gastroenterol Hepatol 2010; 7: 448-458.
3. Ranjit C, Lahiri N. Tissue and serum-associated biomarkers of hepatocellular carcinoma. Biomark Cancer 2016; 8: 37-55.
4. Wollersheim M, Debelka U, Hofschneider PH. A transactivating function encoded in the hepatitis B virus X gene is conserved in the integrated state. Oncogene 1988; 3: 545-552.
5. Levrero M, Zucman-Rossi J. Mechanisms of HBV-induced hepatocellular carcinoma. J Hepatol 2016; 64: S84-S101.
6. Saigo K, Yoshida K, Ikeda R, Sakamoto Y, Murakami Y, Urashima T et al. Integration of hepatitis B virus DNA into the myeloid/lymphoid or mixed-lineage leukemia (MLL4) gene and rearrangements of MLL4 in human hepatocellular carcinoma. Hum Mutat 2008; 29: 703-708.
7. Sung WK, Zheng H, Li S, Chen R, Liu X, Li Y et al. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 2012; 44: 765-769.
8. Ding D, Lou X, Hua D, Yu W, Li L, Wang J et al. Recurrent targeted genes of hepatitis B virus in the liver cancer genomes identified by a next-generation sequencing-based approach. PloS Genet 2012; 8: e1003065.
9. Lau CC, Sun T, Ching AKK, He M, Li JW, Wong AM et al. Viral-human chimeric transcript predisposes risk to liver cancer development and progression. Cancer Cell 2014; 25: 335-349.
10. Liang H-W, Wang N, Wang Y, Wang F, Fu Z, Yan X et al. Hepatitis B virus-human chimeric transcript HBx-LINE1 promotes hepatic injury via sequestering cellular microRNA-122. J Hepatol 2016; 64: 278-291.
11. Shukla R, Upton KR, Munoz-Lopez M, Gerhardt DJ, Fisher ME, Nguyen T et al. Endogenous retrotransposition activates oncogenic pathways in hepatocellular carcinoma. Cell 2013; 153: 101-111.
12. Startek M, Szafranski P, Gambin T, Campbell IM, Hixson P, Shaw CA et al. Genomewide analyses of LINE-LINE-mediated nonallelic homologous recombination. Nucleic Acids Res 2015; 43: 2188-2198.
13. Pollicino T, Squadrito G, Cerenzia G, Cacciola I, Raffa G, Craxi A et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology 2004; 126: 102-110.
14. De Mitri MS, Cassini R, Bernardi M. Hepattits B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear and occult infection. Eur J Cancer 2010; 46: 2178-2186.
15. Wong DKH, Huang FY, Lai CL, Poon RTP, Seto WK, Fung IF et al. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma. Hepatology 2011; 54: 829-836.
16. Mulrooney-Cousins PM, Michalak TI. Asymptomatic hepadnaviral persistence and its consequences in the woodchuck model of occult hepatitis B virus infection. J Clin Transl Hepatol 2015; 3: 211-209.
17. Mason WS. Animal models and molecular biology of hepadnavirus infection. Cold Spring Harb Perspect Med 2015; 5: a021352.
18. Mulrooney-Cousins PM, Chauhan R, Churchill ND, Michalak TI. Primary seronegative hepadnaviral infection engages liver and induces hepatocellular carcinoma in the woodchuck model of hepatitis B. PLoS Pathog 2014; 10: e1004332.
19. Michalak TI, Pardoe IU, Coffin CS, Churchill ND, Freake DS, Smith P et al. Occult life-long persistence of infectious hepadnavirus and residual liver inflammation in woodchucks convalescent from acute viral hepatitis. Hepatology 1999; 29: 928-938.
20. Korba BE, Wells FV, Baldwin B, Cote PJ, Tennant BC, Popper H et al. Hepatocellular carcinoma in woodchuck hepatitis virus infected woodchucks. Presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections. Hepatology 1989; 9: 461-470.
21. Tennant BC, Toshkov IA, Peek SF, Jacob JR, Menne S, Hornbuckle WE et al. Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection. Gastroenterology 2004; 127: 283-293.
22. Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I et al. Infection of a human cell line by hepatitis B virus. Proc Natl Acad Sci USA 2002; 99: 15655-15660.
23. Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z et al. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. Elife 2012; 1: e00049.
24. Guy CS, Mulrooney-Cousins PM, Churchill ND, Michalak TI. Intrahepatic expression of genes affiliated with innate and adaptive immune responses immediately after invasion and during acute infection with woodchuck hepadnavirus. J Virol 2008; 82: 8579-8591.
25. Hantz O, Parent R, Durantel D, Gripon P, Guguen-Guillouzo C, Zoulim F. Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells. J Gen Virol 2009; 90: 127-135.
26. Schulze A, Mills K, Weiss TS, Urban S. Hepatocyte polarization is essential for the productive entry of the hepatitis B virus. Hepatology 2012; 55: 373-383.
27. Michalak TI, Mulrooney PM, Coffin CS. Low doses of hepadnavirus induce infection of the lymphatic system that does not engage the liver. J Virol 2004; 78: 1730-1738.
28. Mason WS, Liu C, Aldrich CE, Litwin S, Yeh MM. Clonal expansion of normal-appearing human hepatocytes during chronic hepatitis B virus infection. J Virol 2010; 84: 8308-8315.
29. Homs M, Buti M, Quer J, Jardi R, Schaper M, Tabernero D et al. Ultra-deep pyrosequencing analysis of the hepatitis B virus preCore region and main catalytic motif of the viral polymerase in the same viral genome. Nucleic Acids Res 2011; 39: 8457-8471.
30. Tagawa M, Omata M, Okuda K. Appearance of viral RNA transcripts in the early stage of duck hepatitis B virus infection. Virology 1986; 152: 477-482.
31. Kock J, Schlicht HJ. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol 1993; 67: 4867-4874.
32. Favre D, Petit MA, Trepo C. Latent hepatitis B virus (HBV) infection and HBV DNA integration is associated with further transformation of hepatoma cells in vitro. ALTEX 2003; 20: 131-142.
33. Mohammadi P, Desfarges S, Bartha I, Joos B, Zangger N, Munoz M et al. 24 hours in the life of HIV-1 in a T cell line. PLoS Pathog 2013; 9: e1003161.
34. De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA et al. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology 2007; 132: 1937-1946.
35. Möröy R, Marchio A, Etiemble J, Trepo C, Tiollais P, Buendia MA. Rearrangement and enhanced expression of c-myc in hepatocellular carcinoma of hepatitis virus infected woodchucks. Nature 1986; 324: 276-279.
36. Takada S, Gotoh Y, Hayashi S, Yoshida M, Koike K. Structural rearrangement of integrated heoatitis B virus DNA as well as cellular flanking DNA is present in chronically infected hepatic tissues. J Virol 1990; 64: 822-828.
37. Xu Y, Wei K, Kulyk W, Gong SG. FLRT2 promotes cellular proliferation and inhibits cell adhesion during chondrogenesis. J Cell Biochem 2011; 112: 3440-3448.
38. Shaul Y, Garcia PD, Schonberg S, Rutter WJ. Integration of hepatitis B virus DNA in chromosome-specific satellite sequences. J Virol 1986; 59: 731-734.
39. Nagaya T, Nakamura T, Tokino T, Tsurimoto T, Imai M, Mayumi T et al. The mode of hepatitis B virus DNA integration in chromosomes of human hepatocellular carcinoma. Genes Dev 1987; 1: 773-782.
40. Merritt RC, Manor U, Salles FT, Grati M, Unrath WC, Quintero OA et al. Myosin IIIB uses an actin-binding motif in its espin-1 cargo to reach the tips of actin protrusions. Curr Biol 2012; 22: 320-325.
41. The Human Protein Atlas. Available http://www.proteinatlas.org/humanproteome. Accessed: 22 March 2016.
42. Fujimoto A, Totoki Y, Abe T, Boroevich KA, Hosoda F, Nguyen HH et al. Wholegenome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators. Nat Genet 2012; 44: 760-764.
43. Richardson SR, Doucet AJ, Kopera HC, Moldovan JB, Garcia-Perez JL, Moran JV. The influence of LINE-1 and SINE retrotransposons on mammalian genomes. Microbiol Spectr 2015; 3: MDNA3 0061-2014.
44. Heikenwalder M, Protzer U. LINE(1)s of evidence in HBV-driven liver cancer. Cell Host Microbe 2014; 15: 249-250.
45. Saitta C, Tripodi G, Barbera A, Bertuccio A, Smedile A, Clancio A et al. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma. Liver Int 2015; 35: 2311-2317.
46. Ting DT, Lipson D, Paul S, Brannigan BW, Akhavanfars S, Coffman EJ et al. Abberrant overexpression of satellite repeats in pancreatic and other epithelial cancers. Science 2011; 33: 593-596.
47. Bersani F, Lee E, Kharchenko PV, Xu AW, Li M, Xega K et al. Pericentromeric satellite repeat expansions through RNA-derived DNA intermediates in cancer. Proc Natl Acad Sci USA 2015; 112: 15148-15153.
48. Balley JA, Carrel L, Chakravarti A, Eichler EE. Molecular evidence for a relationship between LINE-1 elements and X chromosome inactivation: the Lyon repeat hypothesis. Proc Natl Acad Sci USA 2000; 97: 6634-6639.
49. Yuh CH, Ting LP. The genome of hepatitis B virus contains a second enhancer: cooperation of two elements within this enhancer is required for its function. J Virol 1990; 64: 4281-4287.
50. Quarleri J. Core promoter: a critical region where the hepatitis virus make decisions. World J Gastroenterol 2014; 20: 425-435.
51. Chen IH, Huang CJ, Ting LP. Overlapping initiator and TATA box functions in the basal core promoter of hepatitis B virus. J Virol 1995; 69: 3647-3657.
52. Tavis JE, Cheng X, Hu Y, Totten M, Cao F, Michailidis E et al. The hepatitis B virus ribonuclease H is sensitive to inhibitors of the human immunodeficiency virus ribonuclease H and integrase enzymes. Plos Pathog 2013; 9: e1003125.
53. Yang W, Steitz TA. Recombining the structures of HIV integrase, RuvC and RNase H. Structure 1995; 3: 131-134.
54. Oberhaus SM, Newbold JE. Detection of an RNase H activity associated with hepadnaviruses. J Virol 1995; 69: 5697-5704.
55. Bill CA, Summers J, Genomic DNA. double-strand breaks are targets for hepadnaviral DNA integration. Proc Natl Acad Sci USA 2004; 101: 11135-11140.
56. Severeti T, Ying C, Vermeesch JR, Cassiman D, Cnops L, Verslype C et al. Hepatitis B virus replication causes oxidative stress in HepAD38 liver cells. Mol Cell Biochem 2006; 290: 79-85.
57. Dandri M, Burda MR, Brkle A, Zuckerman DM, Will H, Rogler CE et al. Increase in de novo HNV DNA integrations in response to oxidative DNA damage or inhibition of poly(ADP-Ribosyl)ation. Hepatology 2002; 35: 217-223.
58. Zerbini A, Pilli M, Boni C, Fisicaro P, Penna A, Di Vincenzo P et al. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection. Gastroenterology 2008; 134: 1470-1481.
59. Michalak TI, Pasquinelli C, Guilhot S, Chisari FV. Hepatitis B virus persistence after recovery from acute viral hepatitis. J Clin Invest 1994; 93: 230-239.
60. Coffin CS, Michalak TI. Persistence of infectious virus in the offspring of woodchuck mothers recovered from viral hepatitis. J Clin Invest 1999; 104: 203-212.
61. Gujar SA, Mulrooney-Cousins PM, Michalak TI. Repeated exposure to trace amounts of woodchuck hepadnavirus induces molecularly evident infection and virus-specific T cell response in the absence of serological infection markers and hepatitis. J Virol 2013; 87: 1035-1048.
62. Coffin CS, Mulrooney-Cousins PM, van Marle G, Roberts JP, Michalak TI, Terrault NA. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transpl 2011; 17: 955-962.
63. Wheerler TJ, Clements J, Eddy SR, Hubley R, Jones TA, Jurka J et al. Dfam: a database of repetitive DNA based on profile hidden Markov models. Nucleic Acids Res 2013; 41: D70-D82.
64. Vassetzky NS, Kramerov DA. SINEBase: a database and tool for SINE analysis. Nucleic Acids Res 2013; 4: D83-D89.